In this review, we will discuss the actions of CDC25 phosphatases in causing neoplastic growth and cell cycle regulation, the overview of CDC25 inhibitors and efficacy in different cancers and the development of CDC25 inhibitors for cancer therapy both in-vitro and clinical trials, and finally review the complications and future for human cancer treatments. The gene discussed is CDC25C; the disease is cancer.